TAK
Takeda Pharmaceutical Co Ltd
17.40$
-0.1%
vs. previous close
Closing price · As of: Aug 13, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 46.8% | 39.9% | 33.6% | 28.7% | 24.8% | 24.9% | 23.3% | 21.4% | 20.3% | 18.8% | 19.4% | 22.4% | 28.7% | 28.7% | 29.0% | 29.3% | 29.6% | 32.3% | 28.0% | 31.5% | 33.1% | 31.1% | 31.0% | 30.9% | 33.6% | 34.5% | 48.9% | |
| 53.2% | 60.1% | 66.4% | 71.3% | 75.2% | 75.1% | 76.7% | 78.6% | 79.7% | 81.2% | 80.6% | 77.6% | 71.3% | 71.3% | 71.0% | 70.7% | 70.4% | 67.7% | 72.0% | 68.5% | 66.9% | 68.9% | 69.0% | 69.1% | 66.4% | 65.5% | 51.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | 20.8% | 20.2% | 21.5% | 19.1% | 18.0% | 18.4% | 17.6% | 15.0% | 14.3% | 14.7% | 15.7% | 17.1% | 15.9% | 15.0% | |
| 34.6% | – | 38.4% | – | – | – | – | – | – | 54.2% | 45.5% | 45.1% | 53.7% | 52.1% | 26.7% | 28.1% | 36.0% | 35.7% | 35.5% | 34.2% | 29.3% | 27.4% | 24.8% | 24.8% | 24.7% | 24.1% | 22.7% | |
| 34.6% | 36.7% | 38.4% | 41.6% | 41.0% | 40.8% | 43.5% | 43.4% | 49.0% | 61.3% | 51.9% | 51.8% | 53.7% | 63.4% | 62.8% | 78.0% | 63.1% | 58.7% | 58.3% | 60.9% | 63.8% | 53.0% | 56.1% | 56.9% | 61.4% | 58.0% | 39.1% | |
| 18.6% | 23.5% | 28.0% | 29.7% | 34.2% | 34.3% | 33.2% | 35.1% | 30.8% | 19.9% | 28.7% | 25.9% | 17.6% | 7.9% | 8.2% | -7.3% | 7.2% | 9.0% | 13.7% | 9.8% | 3.1% | 15.9% | 12.9% | 12.2% | 5.0% | 7.5% | 12.0% | |
| 0.1% | 0.1% | 0.1% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.1% | 0.1% | 0.1% | 0.1% | 0.2% | 1.8% | 1.8% | 1.8% | 1.3% | 1.8% | 2.3% | 0.0% | 4.1% | 3.4% | 2.9% | 0.0% | 3.0% | 7.9% | |
| 22.0% | 27.3% | 37.2% | 41.3% | 41.1% | 39.3% | 42.7% | 47.9% | 42.0% | 25.9% | 28.4% | 26.2% | 16.7% | 8.3% | 9.4% | -8.2% | 6.7% | 8.3% | 12.3% | 4.5% | -1.8% | 11.5% | 8.5% | 9.3% | 1.2% | 3.8% | 5.8% | |
| 8.8% | 11.8% | 13.4% | 15.1% | 14.5% | 14.3% | 16.6% | 21.9% | 15.9% | 10.5% | 7.9% | 8.5% | 8.3% | -0.2% | 2.9% | -0.1% | 2.1% | 1.6% | 1.7% | -0.7% | -3.2% | -0.3% | 2.0% | 1.4% | -2.1% | 1.5% | 1.5% | |
| 13.0% | 15.2% | 23.4% | 26.0% | 26.3% | 24.7% | 25.8% | 25.7% | 25.9% | 15.2% | 20.3% | 17.5% | 8.2% | 8.4% | 6.3% | -8.2% | 4.4% | 6.6% | 10.6% | 5.2% | 1.3% | 11.8% | 6.4% | 7.9% | 3.4% | 2.4% | 4.3% | |
| 25.7% | 30.9% | 40.1% | 44.2% | 43.7% | 42.1% | 45.1% | 50.1% | 44.3% | 33.7% | 36.3% | 33.8% | 26.8% | 22.6% | 21.8% | 3.2% | 19.4% | 17.1% | 20.3% | 22.1% | 20.4% | 30.8% | 33.2% | 31.9% | 26.8% | 26.4% | 29.7% |
Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.